We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong Holds Campaign for Children with Spinal Muscular Atrophy

By LabMedica International staff writers
Posted on 01 Sep 2022
Print article
Image: A day with SMA children (Photo courtesy of Tianlong)
Image: A day with SMA children (Photo courtesy of Tianlong)

Spinal muscular atrophy (SMA) is an inherited disease that affects the nerves and muscles, causing them to become increasingly weak. SMA affects mostly infants and children and ranks as the foremost fatal genetic disease for infants but can also develop in adults. Tianlong Science and Technology (Shaanxi, China), a leading manufacturer of molecular diagnostic products with a strong focus on social responsibility, recently held a campaign to care for children with SMA.

Tianlong offers PCR reagents covering 200 kinds of disease detection, including SMA. In addition to PCR reagents, Tianlong provides an integrated PCR lab solution from nucleic acid extractors and PCR systems to compatible reagents. Tianlong helped over 80 countries to build their healthcare systems during the COVID-19 pandemic, and the company’s nucleic acid extractors and PCR systems have been at the forefront in the fight against COVID-19. Based on the PCR melting curve method, Tianlong's Human Survival Motor Neuron 1 (SMN1) Gene Detection Kit is suitable for the auxiliary diagnosis of SMN1 patients and screening of SMN1 gene carriers.

Early detection of SMA can help with early diagnosis and treatment of the disease. In May 2022, Tianlong, in association with the SMA Care Center (a non-profit organization for SMA) in China and The Second Affiliated Hospital of Xi'an Jiaotong University, held a campaign aimed to create awareness about SMA and its early detection. During the campaign, Tianlong invited several families in China to join them in accompanying children with SMA for a day. Tianlong also hosted a lecture on SMA treatment and answered concerns of parents of children with SMA. Going forward, Tianlong will continue to work towards creating further awareness about the rare disease among people and identify more SMA children and their families. The company plans to use its advanced technologies for developing additional solutions to better care for SMA children globally.

 

 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
Amoebiasis Test
ELI.H.A Amoeba

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.